ClinicalTrialsFinder

Recurrent Fallopian Tube Cancer Clinical Trials in Oklahoma City, Oklahoma

1 recruitingOklahoma City, Oklahoma

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Endometrial CancerRecurrent Ovarian CancerRecurrent Fallopian Tube Cancer+2 more
Regeneron Pharmaceuticals890 enrolled51 locationsNCT03564340